Paul Tudor Jones Alnylam Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

$29 Billion
Q1 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 1,000 shares of ALNY stock, worth $438,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000

Previous 4,500 77.78%

Holding current value

$438,930

Previous $1.06 Million 74.48%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $13.3 Million - $16.4 Million	-57,007 Reduced 94.39%	3,386 $931,000
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $8.65 Million - $14.9 Million	60,393 New	60,393 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $619,569 - $804,364	4,092 Added 6.82%	64,096 $12.3 Million
Q3 2023 Nov 15, 2023	BUY	$170.77 - $211.65 $8.77 Million - $10.9 Million	51,377 Added 595.54%	60,004 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $1.6 Million - $1.83 Million	8,627 New	8,627 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $3.88 Million - $6.5 Million	28,014 Added 1518.37%	29,859 $5.98 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $222,174 - $312,340	1,845 New	1,845 $269,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $3.06 Million - $4.18 Million	-24,057 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $669,513 - $878,180	-4,196 Reduced 14.85%	24,057 $4.08 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $4.8 Million - $5.87 Million	28,253 New	28,253 $5.33 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $2.45 Million - $3.36 Million	-19,022 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $2.41 Million - $3.34 Million	19,022 New	19,022 $2.69 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $382,138 - $573,665	-3,667 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $193,410 - $278,297	-2,077 Reduced 36.16%	3,667 $399,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $427,985 - $713,577	5,744 New	5,744 $662,000
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $2.13 Million - $2.63 Million	-29,989 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $1.98 Million - $2.78 Million	29,989 New	29,989 $2.18 Million

Others Institutions Holding ALNY

# of Institutions

746

Shares Held

110M

Call Options Held

966K

Put Options Held

841K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $54B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account